 | | NETWORK: N01967 | |
| Entry |
|
|---|
| Name |
|
|---|
| Definition |
SLAMF == SLAMF -> ((SH2D1A,SH2D1B)+(FYN,LCK)),(SHIP,DOK,RASGAP)) |
|---|
| Expanded |
(6504,962,4063,51744,8832,114836,57823) == (6504,962,4063,51744,8832,114836,57823) -> ((4068,117157)+(2534,3932)),((3635,3636),(1796,9046),5921) |
|---|
| Class |
|
|---|
| Type |
Reference
|
|---|
| Pathway |
|
|---|
| Gene |
| 6504 | SLAMF1; signaling lymphocytic activation molecule family member 1 |
| 4063 | LY9; lymphocyte antigen 9 |
| 51744 | CD244; CD244 molecule |
| 114836 | SLAMF6; SLAM family member 6 |
| 57823 | SLAMF7; SLAM family member 7 |
| 4068 | SH2D1A; SH2 domain containing 1A |
| 117157 | SH2D1B; SH2 domain containing 1B |
| 2534 | FYN; FYN proto-oncogene, Src family tyrosine kinase |
| 3932 | LCK; LCK proto-oncogene, Src family tyrosine kinase |
| 3635 | INPP5D; inositol polyphosphate-5-phosphatase D |
| 3636 | INPPL1; inositol polyphosphate phosphatase like 1 |
| 1796 | DOK1; docking protein 1 |
| 9046 | DOK2; docking protein 2 |
| 5921 | RASA1; RAS p21 protein activator 1 |
|
|---|
| Reference |
|
|---|
| Authors |
Farhangnia P, Ghomi SM, Mollazadehghomi S, Nickho H, Akbarpour M, Delbandi AA |
|---|
| Title |
SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Li J, Fan T, Wang D, Xiao C, Deng Z, Cai W, Ji Y, Li C, He J |
|---|
| Title |
SLAMF receptors: key regulators of tumor progression and emerging targets for cancer immunotherapy. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Ishibashi M, Morita R, Tamura H |
|---|
| Title |
Immune Functions of Signaling Lymphocytic Activation Molecule Family Molecules in Multiple Myeloma. |
|---|
| Journal |
|
|---|
| Reference |
|
|---|
| Authors |
Schwartzberg PL, Mueller KL, Qi H, Cannons JL |
|---|
| Title |
SLAM receptors and SAP influence lymphocyte interactions, development and function. |
|---|
| Journal |
|
|---|
| LinkDB |
|
|---|
|
|